Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Toxicol Pathol. 2012 Nov 2;41(5):10.1177/0192623312464304. doi: 10.1177/0192623312464304

Table 2.

Incidences of hyperplasia in the large intestine in heterozygous F1 p53+/− mice in the 40-week feed study of senna.

Dose
(ppm)
Survivala Final
weight
relative
to
controls
(%)
Cecum Colon Rectum
Epithelial
hyperplasia
Epithelial
hyperplasia
Epithelial
hyperplasia
Male
0 25/25 0/25b 0/25 0/24
100 24/25 101 0/25 0/25 0/25
300 25/25 104 0/25 0/25 0/25
1,000 25/25 98 0/25 0/25 0/25
3,000 23/25 101 0/23 3/24 (1.3) 0/24
10,000 24/25 95 22/25* (1.4)c 25/25* (2.8) 1/25 (2.0)

Female
0 23/25 0/25 0/25 0/25
100 23/25 99 0/25 0/25 0/25
300 23/25 96 0/25 0/25 0/25
1,000 22/25 99 0/25 0/25 0/25
3,000 22/25 97 0/25 7/25* (1.0) 0/25
10,000 24/25 93 19/25* (1.3) 25/25* (2.7) 1/25 (1.0)
*

Significantly different (P≤0.01) from the control group by the Fisher exact test

a

Number of animals surviving at 40 weeks/number initially in group

b

Number of animals with lesion

c

Average severity grade of lesions in affected animals: 1=minimal, 2=mild, 3=moderate, 4=marked